Know Cancer

or
forgot password


Phase 2
18 Years
N/A
Not Enrolling
Both
Urologic Neoplasms

Thank you

Trial Information


Inclusion Criteria:



- You must have been diagnosed with bladder cancer that has recurred or moved to a
new part of the body.

- You must have at least one tumor that can be physically measured or scanned by x-ray.

- You may not have had previous chemotherapy (drug) treatment OR you have had surgery
followed by one chemotherapy treatment at least 4 months ago.

Exclusion Criteria:

- You may not have used an experimental medicine or device within the past month.

- Cancer that has spread to your brain.

- If you are unwilling or unable to take folic acid or vitamin B12 supplements.

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

4699

NCT ID:

NCT00034593

Start Date:

Completion Date:

Related Keywords:

  • Urologic Neoplasms
  • Bladder cancer
  • metastatic
  • transitional cell carcinoma of the urothelium
  • Neoplasms
  • Carcinoma, Transitional Cell
  • Urologic Neoplasms

Name

Location